Dose finding/pharmacokinetic study of progesterone as a steroid sparing agent against oedema occurring during secondary brain cancer treatment (NIHR EME:130966)
Progesterone as a steroid-sparing agent against oedema occurring with secondary brain cancers
Read about the @ProssperTrial registered at the #ISRCTN registry
https://t.co/LqHYDslsh0